Healthcare Industry News: Procter & Gamble
News Release - January 16, 2009
Bausch & Lomb Names Peter Valenti, III, as President, North America, Vision CareROCHESTER, N.Y., Jan. 16 -- (Healthcare Sales & Marketing Network) -- Bausch & Lomb, the global eye health company, announced today that Peter Valenti, III, will join Bausch & Lomb as president, North America, Vision Care, effective later this month.
"Pete possesses deep leadership experience, as well as considerable eye health and general healthcare expertise," said Stuart Heap, corporate vice president and global president, Vision Care, Bausch & Lomb. "His appointment further strengthens our existing team, which is focused on delivering innovation in the contact lens, lens care and vision accessories segments of the industry."
Mr. Valenti was most recently vice president and general manager, Surgical Devices (U.S.), for Covidien, where he led sales and marketing strategy for its $1 billion product portfolio. Prior, he spent 12 years with Johnson & Johnson, serving in a variety of U.S. and international roles across consumer, pharmaceutical and device businesses. These included positions as vice president, Global Strategy, and vice president, U.S. Marketing, both in Vision Care. Before his career with Johnson & Johnson, he held several brand management roles with Procter & Gamble.
Mr. Valenti earned an MBA from the Johnson School of Management at Cornell University, and a Bachelor's degree from the University of Connecticut. He will be based in Rochester, N.Y.
About Bausch & Lomb
Bausch & Lomb is the eye health company dedicated to perfecting vision and enhancing life for people around the world. Its core businesses include contact lenses and lens care products, ophthalmic surgical devices and instruments, and ophthalmic pharmaceuticals. Bausch & Lomb is one of the best-known and most respected healthcare brands in the world. Founded in 1853, the company is headquartered in Rochester, N.Y., and employs more than 10,000 people worldwide. Its products are available in more than 100 countries. More information is available at www.bausch.com.
Source: Bausch & Lomb
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.